303 related articles for article (PubMed ID: 21950596)
1. Recent progress and clinical importance on pharmacogenetics in cancer therapy.
Soh TI; Yong WP; Innocenti F
Clin Chem Lab Med; 2011 Oct; 49(10):1621-32. PubMed ID: 21950596
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics, pharmacogenomics and personalized medicine: are we there yet?
Davies SM
Hematology Am Soc Hematol Educ Program; 2006; ():111-7. PubMed ID: 17124048
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
6. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology.
Marquart J; Chen EY; Prasad V
JAMA Oncol; 2018 Aug; 4(8):1093-1098. PubMed ID: 29710180
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman R
Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
[TBL] [Abstract][Full Text] [Related]
9. Genomics and the History of Precision Oncology.
Doroshow DB; Doroshow JH
Surg Oncol Clin N Am; 2020 Jan; 29(1):35-49. PubMed ID: 31757312
[TBL] [Abstract][Full Text] [Related]
10. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in pharmacogenomics in oncology].
Robert J; Bonnet J
Bull Cancer; 2004 Jan; 91(1):19-28. PubMed ID: 14975802
[TBL] [Abstract][Full Text] [Related]
12. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
Roses AD
Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of treatments for pancreatic cancer.
El Hassouni B; Li Petri G; Liu DSK; Cascioferro S; Parrino B; Hassan W; Diana P; Ali A; Frampton AE; Giovannetti E
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):437-447. PubMed ID: 31100206
[No Abstract] [Full Text] [Related]
14. Pharmacogenomics in the treatment of lung cancer: an update.
Morales-Espinosa D; García-Román S; Karachaliou N; Rosell R
Pharmacogenomics; 2015; 16(15):1751-60. PubMed ID: 26427522
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
Olivera GG; Urtasun A; Sendra L; Aliño SF; Yáñez Y; Segura V; Gargallo P; Berlanga P; Castel V; Cañete A; Herrero MJ
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575974
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials.
Burczynski ME; Oestreicher JL; Cahilly MJ; Mounts DP; Whitley MZ; Speicher LA; Trepicchio WL
Curr Mol Med; 2005 Feb; 5(1):83-102. PubMed ID: 15720272
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
O'Donnell PH; Stadler WM
Clin Cancer Res; 2012 May; 18(10):2809-16. PubMed ID: 22427349
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
[TBL] [Abstract][Full Text] [Related]
19. Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.
Garrison LP; Austin MJ
Health Aff (Millwood); 2006; 25(5):1281-90. PubMed ID: 16966724
[TBL] [Abstract][Full Text] [Related]
20. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
Huang RS; Dolan ME
Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
